PMID: 9185416Mar 1, 1997Paper

Experiences and studies on antimicrobial resistance in Japan: useful lessons for developing countries

East African Medical Journal
Y Kamiya

Abstract

The use of antimicrobial drugs in Japan is remarkably high. In 1994, the total production cost of antimicrobial drugs amounted to 3.38 billion US dollars. The intensive use of broad-spectrum drugs, especially for treatment of increasing number of immunocompromised and elderly patients, resulted in the emergence and spread of antimicrobial-resistant organisms in Japan. A bacteriological study in a chronic care centre shows a variety of bacterial pathogens with increased antimicrobial resistance such as methicillin-resistant Staphylococcus aureus. Control measures of nosocomial infections with resistant organisms have been established and strengthened. This includes surveillance researches such as re-evaluation of disinfectants.

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinics in Chest Medicine
S K Fridkin, R P Gaynes
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sara E Cosgrove
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J Chastre
Nature Reviews. Microbiology
E Yoko Furuya, Franklin D Lowy
© 2021 Meta ULC. All rights reserved